FDA Approved: SYNJARDY — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved SYNJARDY (empagliflozin and metformin hydrochloride) as an Original Application for the treatment of type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SYNJARDY (empagliflozin and metformin hydrochloride)

Snippet

ORIG AP for SYNJARDY (EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE)